UnknownNot Applicable

Axillary Reverse Mapping (ARM) Technique

Canada130 participantsStarted 2016-11

Plain-language summary

The purpose of this pilot study is to compare a new surgical technique (axillary reverse mapping) to standard axillary surgery in patients diagnosed with invasive or in situ breast cancer.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. mastectomy and sentinel lymph node biopsy
✓. breast conserving surgery or mastectomy and axillary lymph node dissection
✓. completion axillary lymph node dissection after positive sentinel lymph node biopsy
✓. cases receiving neo-adjuvant therapy (chemotherapy or hormonal therapy) who are having axillary lymph node dissection as part of their surgical treatment -

Exclusion criteria

✕. males with breast cancer
✕. women less than 18 years of age
✕. known allergic reaction to patent blue dye
✕. pregnant
✕. previous radiation therapy to affected side
✕. clinical N2/N3 disease -

What they're measuring

Lymphedema

Timeframe: Change from baseline to 6 months post-operative

Lymphedema

Timeframe: Change from baseline to 12 months post-operative

Trial details

NCT IDNCT03109522

SponsorMcMaster University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-09

View on ClinicalTrials.gov More Invasive Breast Cancer trials